Cardiac risk with antispasmodic medication

A Medicines Safety Update from the TGA has reminded health professionals to be cautious with parenteral administration of hyoscine butylbromide (Buscopan) via intramuscular or slow intravenous injection. The Product Information for hyoscine butylbromide is being updated to include a stronger warning about its use in patients with cardiac conditions. The updated PI will advise that ...

Already a member?

Login to keep reading.

© 2021 the limbic